These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 21917650

  • 1. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.
    Xu L, Li X, Chu ES, Zhao G, Go MY, Tao Q, Jin H, Zeng Z, Sung JJ, Yu J.
    Gut; 2012 Jul; 61(7):977-85. PubMed ID: 21917650
    [Abstract] [Full Text] [Related]

  • 2. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM, Jin H, To KF, Chan FK, Sung JJ.
    Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
    [Abstract] [Full Text] [Related]

  • 3. B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice.
    Wang J, Dong L, Xu L, Chu ES, Chen Y, Shen J, Li X, Wong CC, Sung JJ, Yu J.
    Cancer Lett; 2014 Dec 28; 355(2):192-200. PubMed ID: 25218345
    [Abstract] [Full Text] [Related]

  • 4. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X, Cheung KF, Ma X, Tian L, Zhao J, Go MY, Shen B, Cheng AS, Ying J, Tao Q, Sung JJ, Kung HF, Yu J.
    Oncogene; 2012 Jul 19; 31(29):3419-30. PubMed ID: 22105368
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB, Han F, Du XH, Jiang X, Li YH, Liu Y, Chen HQ, Ao L, Cui ZH, Cao J, Liu JY.
    Int J Cancer; 2014 Mar 15; 134(6):1311-22. PubMed ID: 24037716
    [Abstract] [Full Text] [Related]

  • 6. Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer.
    Yang Q, Gao J, Xu L, Zeng Z, Sung JJ, Yu J.
    Biomarkers; 2013 Dec 15; 18(8):721-5. PubMed ID: 24191714
    [Abstract] [Full Text] [Related]

  • 7. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer.
    Cheng YY, Yu J, Wong YP, Man EP, To KF, Jin VX, Li J, Tao Q, Sung JJ, Chan FK, Leung WK.
    Br J Cancer; 2007 Oct 08; 97(7):895-901. PubMed ID: 17848950
    [Abstract] [Full Text] [Related]

  • 8. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
    Wanajo A, Sasaki A, Nagasaki H, Shimada S, Otsubo T, Owaki S, Shimizu Y, Eishi Y, Kojima K, Nakajima Y, Kawano T, Yuasa Y, Akiyama Y.
    Gastroenterology; 2008 Aug 08; 135(2):580-90. PubMed ID: 18588891
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer.
    Ooki A, Yamashita K, Yamaguchi K, Mondal A, Nishimiya H, Watanabe M.
    Mol Cancer Res; 2013 Nov 08; 11(11):1362-74. PubMed ID: 23982217
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
    Deng J, Liang H, Ying G, Dong Q, Zhang L, Yu J, Fan D, Hao X.
    J Am Coll Surg; 2014 Nov 08; 219(5):904-13. PubMed ID: 25260683
    [Abstract] [Full Text] [Related]

  • 13. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.
    Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S, Wu CW, Wu WK, He M, Wang M, Ng SS, Sung JJ.
    Oncogene; 2010 Dec 09; 29(49):6464-74. PubMed ID: 20802524
    [Abstract] [Full Text] [Related]

  • 14. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
    Byun DS, Cho K, Ryu BK, Lee MG, Kang MJ, Kim HR, Chi SG.
    Cancer Res; 2003 Nov 01; 63(21):7068-75. PubMed ID: 14612497
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer.
    Kanda M, Shimizu D, Nomoto S, Hibino S, Oya H, Takami H, Kobayashi D, Yamada S, Inokawa Y, Tanaka C, Fujii T, Sugimoto H, Koike M, Fujiwara M, Kodera Y.
    J Surg Oncol; 2014 Aug 01; 110(2):136-44. PubMed ID: 24700496
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypermethylation-mediated reduction of LMX1A expression in gastric cancer.
    Dong W, Feng L, Xie Y, Zhang H, Wu Y.
    Cancer Sci; 2011 Feb 01; 102(2):361-6. PubMed ID: 21159062
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
    Yu J, Liang Q, Wang J, Wang K, Gao J, Zhang J, Zeng Y, Chiu PW, Ng EK, Sung JJ.
    Oncogene; 2017 Jan 12; 36(2):182-193. PubMed ID: 27212034
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.